Having trouble viewing this email? View the online version.
ISSM logo

Latest News from the ISSM - March 30, 2018 Member Login
SMSNA Issues Position Statement on Restorative ED Therapies

Last week, the Sexual Medicine Society of North America (SMSNA) released a position statement regarding the use of restorative (regenerative) therapies for erectile dysfunction (ED), particularly shock wave, platelet rich plasma, and stem cell therapies. 

The SMSNA considers these therapies "experimental" and states that these treatments "should be conducted under research protocols in compliance with Institutional Review Board approval." 

Please see the full statement here. 

After RALP, Men Might Benefit from Immediate Rehabilitation

Men who undergo penile rehabilitation with sildenafil immediately after prostatectomy may have better outcomes than men whose treatment is delayed, experts report in the Journal of Urology.

The study involved 124 men who underwent nerve-sparing robot-assisted laparoscopic prostatectomy (NS-RALP). The men were randomly assigned to one of two groups. One group started taking sildenafil immediately after their urethral catheter was removed after surgery. The other group began their sildenafil treatment three months after surgery. 

After twelve months, over 40% of the men in the early group had recovered their full erectile function. Only 18% of the delayed group reached this benchmark. 

Men in the early group were also more likely to penetrate a partner and maintain their erection throughout sexual encounters. 

Please see more details on the study here. 

New Research: Low-Intensity Shockwave Therapy for ED

A new study on low-intensity shockwave therapy for the treatment of erectile dysfunction (ED) is the subject of our website's latest research summary. 

"Low-Intensity Shockwave Therapy for Erectile Dysfunction: A Randomized Clinical Trial Comparing 2 Treatment Protocols and the Impact of Repeating Treatment" by Dr. Dimitrios Kalyvianakis, et al., was published online last month in the Journal of Sexual Medicine. 

This two-phase study examined the safety and efficacy of low-intensity shockwave therapy, comparing 6- and 12-session regimens and investigating the value of an additional period of therapy.  

Please click here to see the summary. 

Note: Last week, the Sexual Medicine Society of North America issued a position statement on restorative therapies for ED, including LiST.)

You are receiving this newsletter because you are subscribed to our mailing list.
If you would rather not receive emails like this in the future you can unsubscribe.

ISSM | International Society for Sexual Medicine
P.O. Box 94 | 1520 AB Wormerveer | The Netherlands